PLIN3 and neoplasm: The results indicated that patients with enhanced PLIN3+ tumor cells had relatively low ratio and numbers of CD3+ T cells and CD3+CD4+ helper/inducer T cells in blood (Fig. 3b, e), whereas significance was lost within immunocytes (Fig. 3c, f) and fibroblasts (Fig. 3d, g).